Colleges are the champions of medical research as a discarded drug from GlaxoSmithKline is being resurrected and revised to potentially help human cells fight off viruses like Ebola, dengue, Zika, and many others.
Instead of fighting the virus head-on, a group at Stanford decided to tackle the problem from a different perspective by helping the body resist the virus. In the lab, researchers have been able to help human cells fight two disease-causing viruses, and hope to apply this tactic to other viruses.
Standford reserachers published their findings in Nature Chemical Biology in the March 28th edition. Chaitan Khosia, one of the senior authors of the paper, explained how the mechanism of the drug allows it to be effective against viruses that use RNA, not DNA, as thier genetic material.
Although this is good news for the future fight against RNA viruses, the drug has only been proven effective in lab cell samples. The next step, testing it in the real world.
Source: Standford News